Authors:
Ishimaru, M
Morikawa, K
Hifumi, E
Itoh, T
Uda, T
Citation: M. Ishimaru et al., Analysis of the antigen recognition sites of anti-methamphetamine monoclonal antibodies (II): Unique feature of MA-3 antibody, J BIOSCI BI, 89(5), 2000, pp. 492-494
Citation: E. Hifumi et al., Design of an artificial molecular catalyst showing peptidase activity to the conserved sequence of HIV-1 envelope gp41, J MOL CAT A, 155(1-2), 2000, pp. 209-218
Authors:
Nishimura, T
Hifumi, E
Fujii, T
Niimi, Y
Egashira, N
Shimizu, K
Uda, T
Citation: T. Nishimura et al., Measurement of Helicobacter pylori using anti its urease monoclonal antibody by surface plasmon resonance, ELECTROCH, 68(11), 2000, pp. 916-919
Citation: T. Uda et al., Catalytic activity of antibody light chain to gp41: A consideration of refolding in relation to activation mechanism, CHEM IMMUNO, 77, 2000, pp. 18-32
Citation: N. Egashira et al., Fabrication of a miniaturized cell based on electrochemiluminescence of Ru(bpy)(3)(2+) and its application to the determination of some peptides, BUNSEKI KAG, 49(12), 2000, pp. 1029-1031
Citation: E. Hifumi et al., How and why 41S-2 antibody subunits acquire the ability to catalyze decomposition of the conserved sequence of gp41 of HIV-1, APPL BIOC B, 83(1-3), 2000, pp. 209-219
Citation: E. Hifumi et al., Super catalytic antibody [I]: Decomposition of targeted protein by its antibody light chain, J BIOSCI BI, 88(3), 1999, pp. 323-327
Authors:
Hifumi, E
Morihara, F
Ishimaru, M
Morikawa, K
Shimizu, K
Uda, T
Citation: E. Hifumi et al., Immunochemical features of complementarity determining region (CDR) peptide in anti hemin monoclonal antibody, J PEPT SCI, 5(1), 1999, pp. 24-31